IP Library Granted Patent US 7,867,721
Granted Patent B2
US 7,867,721 · App. 11/703,343 · Granted Jan 11, 2011

In vitro method for identifying a compound using an eukaryotic mechanosensory transduction channel

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,867,721
App. No.
11/703,343
Granted
Jan 11, 2011
Kind
B2
Abstract

The present invention provides, for the first time, nucleic acids encoding a eukaryotic mechanosensory transduction channel (MSC) protein. The proteins encoded by these nucleic acids form channels that can directly detect mechanical stimuli and convert them into electrical signals. These nucleic acids and the proteins they encode can be used as probes for sensory cells in animals, and can be used to diagnose and treat any of a number of human conditions involving inherited, casual, or environmentally-induced loss of mechanosensory transduction activity.

Claims (9)

1. An in vitro method for identifying a compound that modulates mechanosensory receptor activity in eukaryotic cells, the method comprising the steps of:

(i) contacting the compound with a mechanosensory receptor protein, the protein having cation channel activity and comprising a sequence with 90% or greater identity to the sequence of SEQ ID NO:4; and

(ii) determining the functional effect of the compound on the mechanosensory receptor protein, thereby identifying a compound that modulates said mechanosensory receptor activity.

2. The method of claim 1 , wherein the mechano sensory receptor protein is expressed in a eukaryotic cell or cell membrane.

3. The method of claim 2 , wherein the functional effect is determined by detecting a change in the membrane potential of the cell or cell membrane.

4. The method of claim 2 , wherein the functional effect is determined by detecting a change in an intracellular ion concentration.

5. The method of claim 4 , wherein the ion is selected from the group consisting of K + and Ca 2+ .

6. The method of claim 1 , wherein the protein comprises the amino acid sequence of SEQ ID NO:4.

7. The method of claim 1 , wherein the protein is recombinant.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 23, 2011
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026320/0722 →
Continuity (3)
Continuation 1036997800 · Feb 18, 2003
Division 0939281200 · Sep 9, 1999
Related Publication 20090075294A1 · Mar 19, 2009